Positron emission tomography (PET) for cholangiocarcinoma.
- Breitenstein S Swiss HPB (Hepato-pancreato-Biliary) Center, Department of Surgery, University Hospital Zurich, Switzerland.
- Apestegui C
- Clavien PA
- 2008-09-06
Published in:
- HPB : the official journal of the International Hepato Pancreato Biliary Association. - 2008
English
The combination of positron emission tomography (PET) with computed tomography (PET-CT) provides simultaneous metabolic and anatomic information on tumors in the same imaging session. Sensitivity of PET/PET-CT is higher for intrahepatic (>90%) than for extrahepatic cholangiocarcinoma (CCA) (about 60%). The detection rate of distant metastasis is 100%. PET, and particularly PET-CT, improves the results and impacts on the oncological management in CCA compared with other imaging modalities. Therefore, PET-CT is recommended in the preoperative staging of intrahepatic (strength of recommendation: moderate) and extrahepatic (strength of recommendation: low) CCA.
- Language
-
- English
- Open access status
- bronze
- Identifiers
-
- DOI 10.1080/13651820801992583
- PMID 18773069
- Persistent URL
- https://sonar.ch/global/documents/211113
Statistics
Document views: 63
File downloads:
- Full-text: 0